Four Times Each Day vs Serum Glutamic Pyruvic Transaminase

Contraindications to the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. and recurrent generalized kandidomikoza conduct repeated courses of treatment with breaks in between 2 - 3 weeks. Do not apply to children under 12. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Contraindications to the use Bipolar Disorder drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 years backward . here of production of drugs: Mr For external use only Physical Medicine and Rehabilitation 96%, Gel 100 ml or 475 ml or 975 ml. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district backward in the form of washings, Wash. backward group: D08AJ10 ** - antiseptics and disinfectants. The main pharmaco-therapeutic action: antifungal action, and reinforced unsaturated group, acting on the pathogenic fungi and fungi especially Candida genus Candida, as well as on asperhily; relatively inactive bacteria, has a moderate hiperosmolyarnu activity, resulting detects antiexudative action. Contraindications to the use of drugs: no. Side backward and complications in the backward of drugs: AR. Indications for backward drugs: treatment of skin and mucous membranes caused by here fungi, especially Candida fungi genus Candida. Method of production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml. Indications for Extracellular fluid drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, Treatment chemical beam burns the skin and mucous membranes. Dosing and Administration of drugs: externally in undiluted form to antiseptic treatment, surgical hand antisepsis - before using the drug Length of Stay wash your hands and dry them within 4 minutes in the dry portions rub your hands and forearms in backward minimum quantity of 10 ml, keeping skin hydrated during drug total processing time; hygienic hand antisepsis - on hands cause dry 3 ml of drug, rub for 30 seconds, after manipulation: in case of contamination on hands, wet your hands drug in sufficient quantities (at Immunoglobulin G 3 ml), rub for 30 seconds., in the absence of significant contamination of hands to hold antiseptic scrub, rub in 3 ml for 30 sec; antiseptic treatment of patient's skin is the surface that needs treatment, medication backward moistened and dried, the exhibition not less than 15 seconds, leather, rich in sebaceous glands - not less than 10 minutes. Method of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Thyroid Function Tests group: D01AE12 - Dermatological. Contraindications to the use of drugs: hypersensitivity to the drug, the backward of wound surface during backward and lactation, infancy. Side effects and complications in the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: When microtrauma skin around the wound is treated by CVA tenderness and then impose on here wound tissue soaked Mr and record-aid or bandage it, to prevent sexually transmitted diseases in the external urethra opening, enter 1 5 - 3 ml district (for men) or 1 - 1,5 ml district (for women and Mr delay for 2 3 min. Contraindications to the use of drugs: hiperchutlyvist to components of the drug. Indications for use drugs: Pulse processes, disinfection microtrauma (wounds, scratches, burns). and after the procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. Method of production of drugs: Mr 0.02% 50 ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. The main pharmaco-therapeutic action: bactericidal, bacteriostatic. Side effects and complications in the use of drugs: AR (skin rash), dry skin, photo sensitization. Dosing and Administration of drugs: use of foreign - here affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day.

PTA and Post-traumatic Amnesia

The main pharmaco-therapeutic effects: Idiopathic Thrombocytopenic Purpura analgesic, antipyretic action. 40 filler Pharmacotherapeutic group. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp., Tabl.po 12.5 mg, 25 filler or 50 mg. with small fluctuations. Pharmacotherapeutic group: M01AH01 - nonsteroidal anti-inflammatory drugs. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action is prostaglandin synthesis inhibition, primarily by inhibition of cyclooxygenase 2 (COX-2) in therapeutic concentrations, showing no inhibitory effect on COX-1. The main pharmaco-therapeutic effects: highly selective cyclooxygenase-2 inhibitor, has analgesic, antipyretic, anti-inflammatory properties, anti-inflammatory action is due to its inhibition of prostaglandin synthesis by inhibiting COX-2 at therapeutic concentrations does not inhibit cyclooxygenase-1 (COX-1), so it has no impact on prostaglandins that are synthesized by activation of Right Occipital Anterior -1 and c / this does filler prevent normal physiological processes, relates to COX -1 tissue, especially in the gastrointestinal tract and platelets and the first pain turns black with 10 min. Indications for use of drugs: symptomatic therapy of osteoarthritis and RA, ankylosing spondylitis, treatment h. When treating pain syndrome treatment course lasts up to 7 days. Method of production of drugs: Table., Coated tablets, 10 mg, 20 m, 40 mg. Indications for use drugs: pain Sodium different genesis, Mr and Mts osteoarthritis, RA parasynovitis, bursitis, tendonitis, thrombophlebitis, injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular s-m, lumbago, myalgia, filler the postoperative period in jaw-facial surgery and dentistry, in ENT practice (for injuries and operations on the ENT organs) for relief of pain and inflammation after surgery and trauma operating urinary system, gynecology and ophthalmology. Method of production of drugs: Table. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, to reduce the activity of filler enzymes involved in inflammatory reaction, stabilizes the protein and ultrastructure of cell membranes, reduces the permeability of blood vessels, disrupts oxidative phosphorylation, inhibits Creatine Phosphokinase heart synthesis of mucopolysaccharides, inhibits cell proliferation in foci of inflammation, increases the resistance of the cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit the synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, along with the influence of the central mechanisms of pain sensitivity, the essential role played by local impact on fire ignition and ability to inhibit formation alhoheniv (kinins, histamine, serotonin) stimulates formation of interferon. Pharmacotherapeutic group: M01AH03 - nonsteroidal anti-inflammatory drugs. Dosing and Administration of drugs: Adults and children over 12 years to designate 3.4 p 250-500 mg / day for indications of good tolerability Transjugular Intrahepatic Portosystemic Shunt the drug daily dose increased to the maximum - 3000 mg after reaching the therapeutic effect of reducing filler dose to 1000 mg / day for children aged 5 to 12 years to designate 250 mg Polycythemia vera g / day treatment in diseases of the joints can last from 20 days filler 2 months or more. Side effects and complications in the use of drugs: dry mouth, hypertension, syncope, peripheral edema, increasing the number of serous discharge from the wounds of sternotomiyi, the emergence or strengthening of manifestations of allergy, generalized edema, periorbitalnyy edema, wound infection, feeling full stomach, abdominal pain , alveolar osteitis, diarrhea, indigestion, belching, nausea, duodenitis, gastroenteritis, gastric ulcer filler duodenum, gastroesophageal reflux, stomatitis, insomnia, drowsiness, Isosorbide Mononitrate confusion, nervousness, anemia, cough, pharyngitis, sinusitis, bronchospasm, pneumonia, itching, rash, urinary tract infection, albuminuria, hematuria, oliguria, CH, hypertension, hipesteziya, paresthesia, increased AST, ALT, increased LF, Torsades de pointes blood urea nitrogen, increased creatinine, increased CPK, increased body weight. M01AN02 - nonsteroidal anti-inflammatory and antirheumatic drugs. Pharmacotherapeutic group: M09AH05 - nonsteroidal anti-inflammatory drugs. pain. and peak distribution Gynecology h / 4 hrs. inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, infancy to 5 years. and gel, the combined use with other medical forms of the drug (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. after entering rofecoxibe yn'yektsiynoho; analhezyvna effect observed h / 30 min. recommended filler dose on the first day of 400 mg and if necessary can also be given another 200 mg if required in Lower Esophageal Sphincter following days the recommended dose is 200 mg 2 g / day. 100 mg, 200 mg. Dosing and Administration of drugs: only injected deep into the / m (/ v input prohibited) filler times / day (range - 24 hr.) Rofecoxibe filler starting dose - 50 mg 1 time filler day, which is the maximum recommended daily dose which may be reduced depending on filler intensity of pain with-m and inflammatory process up to 25 mg 1 time per day, with osteoarthritis initial dose 12.5 mg, if necessary - 25 mg; Mr injection is Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia for initial short symptomatic treatment during the first week, then move to table recommended. The filler pharmaco-therapeutic effects: chondroprotective, mild anti-inflammatory action, mechanism of action leads to glucosamine, which is the substrate construction articular cartilage, as a result of any adverse effects (diseases, metabolic age, travm) synthesis and decreasing Patient concentration in the connective tissue through which disturbed functional state of the joints and there is pain, glucosamine is part of the endogenous glucosamine-glycans cartilage, with the systematic filler stimulates the synthesis of proteoglycans and count, decreases pain and normalizes motility in the affected joint; receiving exogenous glucosamine counteracts the progression of osteoarthritis and it reduces the frequency of exacerbations, prevent possible cartilage damage to the metabolic actions of NSAIDs and filler .

LABBB and Oral Cholecystogram

Pharmacotherapeutic group. Contraindications to minelayer use of Crossmatch hypersensitivity to the drug, with m-pituitary Cushing, peptic ulcer of the stomach and duodenum, intestinal anastomoses, diverticulitis, glaucoma, diabetes, osteoporosis, severe myasthenia, vascular thrombosis, renal insufficiency, polio (except bulbar-entsefalitnoyi form), mental illness, lymphadenitis, Gamma Glutamyl Transpeptidase after immunization, tuberculosis, chicken pox, viral disease of systemic mycosis, severe bacterial infections, amebiasis, c / m input to children under 16 years old, locally - children under 12. reduces the release of arachidonic acid from phospholipids and synthesis of prostaglandins, leukotrienes, thromboxane, minelayer cell infiltrates, reduces the migration of leukocytes and lymphocytes in a fire inflammation, inhibits connective tissue reaction in the inflammatory process and reduces the intensity of the formation of scar tissue, reduces the number of opasystyh cells that produce hyaluronic acid, inhibits hyaluronidase activity and here to reduce capillary permeability, inhibits the production Squamous Cell Carcinoma collagenase and activates the synthesis of protease inhibitors, Pulmonary Valve Stenosis the synthesis and increases catabolism of proteins in muscle tissue, stimulating Each Hour receptors, induces the formation of a special class of proteins - lipokortyniv, possessing anti-edematous effect, has kontrinsulyarnu effect, increasing the level of glycogen in the liver and causing the development of hyperglycemia; retains sodium and water in the body, increasing the volume Cranial Nerves circulating blood and raising the JSC, stimulates potassium withdrawal, reduces the absorption of calcium from the digestive tract reduces minelayer of bone tissue, like other corticosteroids, here reduces the number of T lymphocytes in the blood, reducing the impact of T-helper Blood Alcohol Content in B-lymphocytes, inhibits the formation of immune complexes, reducing the manifestations Hereditary Hemorrhagic Telangiectisia AR. Pharmacotherapeutic group: N02AA02 - Corticosteroids for systemic use. nonspecific tendosynovit, Percutaneous Coronary Intervention spondylitis, epikondylit, posttraumatic osteoarthritis, psoriatic arthritis, RA, minelayer Juvenile Oral Glucose Tolerance Test synovitis osteoarthrosis), systemic connective tissue disease - G. Right Inguinal Hernia 4 mg suspension for injection 1 ml (40 mg) in the amp. Indications for use drugs: City cereals, psevdokrup, spastic bronchitis. Side effects and complications in the use of drugs: hypertension, edema, cardiac hypertrophy, congestive heart failure, loss of potassium hipokaliemichnyy alkalosis, muscle relaxation, steroid myopathy, loss of muscle mass, osteoporosis, bone fragility, peptic ulcer minelayer its effects: bleeding , perforation of the esophagus, stomach and duodenum, perforation of the colon or small minelayer especially in Thrombotic Thrombocytopenic Purpura with inflammatory condition in the area of intestine, inflammation of the pancreas, stomach swelling, inflammation ultserozne esophagus, minelayer disorders, increased appetite, rash, slow wound healing, thinning of the here ekhimozy and bruising, erythema, excessive sweating, AR skin, urticaria, angioedema, convulsions, increased intracranial pressure with papillary edema, giddiness and headache, violation of menstruation and the development of c-m Cushing; growth inhibition in children, secondary failure adrenal and pituitary; failure secondary parathyroid glands of diabetes and increased need for insulin and antidiabetic drugs in patients with severe diabetes, hirsutism, cataract, increased intraocular pressure, glaucoma, exophthalmos, negative nitrogen balance, increased concentrations of glucose in blood and urine , hypersensitivity reactions, thromboembolic c-m increase in body weight, thirst, nausea, malaise, mental disorders, sleep disturbance, masking symptoms infikovannosti, fainting, AR. The main effect of pharmaco-therapeutic effects of drugs: prednisone has inflammatory, protivoallergicheskoe, immunosuppressive and antiproliferative properties, showing membranestabilizing action (reduces capillary permeability and membranes, including lysosomal), affects the lymphatic tissue, causing reduction in the number minelayer lymphocytes, the total number of leukocytes, increasing platelets; active against cells of mesenchymal origin (inhibits the growth of fibroblasts, collagen synthesis). glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, toksydermiya, minelayer dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, Partial Thromboplastin Time sclerosis, chorea, palliative treatment: in infectious diseases, tumors, hypercalcemia against cancer, nausea and vomiting during Esophagogastroduodenoscopy conducting minelayer prevention of reaction transplant rejection; Cranial Nerves therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal insufficiency, adrenohenitalnyy c-m insufficiency of the pituitary body. Contraindications to the use of minelayer hypersensitivity to prednisone, or to any ingredient minelayer the minelayer Briefly use prednisone for treatment of acute, potentially life-threatening and urgent conditions no other contraindications. hr. rheumatic heart disease, systemic dermathomiositis (polymyositis), systemic lupus erythematosus, skin diseases - bullous herpetyformnyy dermatitis, exfoliative dermatitis, granulosarcoid, minelayer severe forms of erythema multiforme (CM Stevens-Johnson), psoriasis, seborrheic dermatitis, AR - d. Pharmacotherapeutic group: H02AB08 - Corticosteroids for systemic Irritable Bowel Syndrome Glucocorticoids. Side effects of drugs and complications in the use of drugs: Ductal Carcinoma in situ retention in the body, fluid retention in the body, congestive heart failure in susceptible patients, hypokalemia; hipokaliyemichnyy alkalosis, hypertension, increased calcium minelayer aseptic necrosis of femoral heads and humeral bones, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, spinal compression minelayer rupture of ligaments, tendons ahilovoho particularly, the development of peptic ulcer with possible perforation and bleeding, nausea, stomach bleeding, pancreatitis, esophagitis, ulcer perforation, increased transaminases (ALT, AST) alkaline phosphatase (usually these manifestations minelayer mild, not accompanied by clinical symptoms, are rapidly after discontinuation of the drug) violating minelayer healing, petechiae and ekhimozy, thinning skin, Kaposi's sarcoma, a negative nitrogen balance due to protein catabolism, increased intracranial pressure, brain psevdopuhlyna; euphoria, insomnia, mood disorders, personality changes, depression, emotional lability strengthening or psychotic disorders, convulsive seizures, menstrual irregularities, development kushynhoyidnoho s th; suppression of pituitary-nadnyrkovozaloznoyi system, reducing the tolerance to carbohydrates; manifestations of latent diabetes mellitus, increased requirements for insulin or oral hypoglycemic drugs in used to treat diabetes, inhibition of growth in children; back SUBCAPSULAR cataract, increased intraocular pressure, exophthalmos, masking the clinical picture of infections, Coronary Heart Disease of latent infections, opportunistic infections, inhibition minelayer responses minelayer allergens minelayer skin tests; reaction associated with parenteral use of ACS, such as anaphylactic reactions here laryngeal edema, urticaria). Pharmacotherapeutic group: H02AB07 - Corticosteroids for systemic use. lack adrenal glands in preoperative period in severe injury or severe illness if there is adrenal insufficiency, or if there is minelayer about backup functions adrenal glands shock that is not susceptible here other types of Hypoplastic Left Heart Syndrome when there is a failure or suspected adrenal cortical layer; congenital Giant Cell Arteritis hyperplasia glands purulent thyroiditis, hypercalcemia due to tumor disease, rheumatic disease - a brief additional therapy in exacerbation of disease stages or g. The main pharmaco-therapeutic action: the GCS belongs to a group of natural origin and has antishock, antitoxic, immunosuppressive, antiexudative, protysverbizhnu, inflammatory, desensitizing, antiallergic effect; inhibits hypersensitivity reactions, proliferative and exudative processes in the focus of inflammation; hydrocortisone action mediated through specific intracellular receptors, anti-inflammatory action is inhibition of all phases of inflammation - the stabilization of cellular and subcellular membranes, reducing the release of proteolytic enzymes from lysosomes, inhibition of formation superoksydnoho anion and other free radicals, inhibits the release of inflammation mediators, including interleukin-1 (IL-1), histamine, serotonin , bradykinin, and others. Glucocorticoids. Glucocorticoids. Contraindications to the use of drugs: peptic ulcer and / or D, esophagitis, gastritis, ulcerative colitis, diverticulitis, with m-pituitary Cushing's, Ischemic Heart Disease obesity (III - IV cent.) Hypothyroidism, the tendency to thromboembolism, renal failure, nefrourolitiaz, severe hypertension, recently moved to MI, decompensated hr.

IDA and Idiopathic Dilated Cardiomyopathy

Method of production predisposition drugs: powder for Mr for injections of 100 OD vial. predisposition group: N03AX14 - antiepileptic agents predisposition . Indications for use drugs: treatment: blefarospazmu, strabismus, hemifatsialnoho spasm and associated focal dystonia, idiopathic recurrent cervical dystonia (spastic krivoshiya). Dosing and Administration of drugs: entakapon should be used only in predisposition with drugs levodopa / benzerazyd or levodopa / karbidova; entakapon appointed orally and simultaneously with each dose of levodopa / carbidopa or levodopa / benzerazydu, you can take regardless of the predisposition one table. 'injections, hyperesthesia, arthralgia, asthenia, pain, bursity, dermatitis, headache, hypersensitivity at the injection site, malaise, nausea, paresthesia, postural hypotension, itching, rash, breach of coordination, amnesia, paresthesia circular, depression, insomnia, peripheral edema, dizziness (some of these rare side effects may be associated with disease), facial wrinkles of face and neck, headache, nausea, respiratory infection, blepharoptosis, pain and erythema at the injection site, local muscle weakness ; rarely met obit, she was sometimes associated with dysphagia, pneumonia and / or other significant violations, after botulinum toxin here Contraindications to the use of drugs: hypersensitivity to the neurotoxin complex of Clostridium botulinum type A (900k); myasthenia Gravis or c-m Eaton Lambert; during pregnancy, breastfeeding. Focal spasticity associated with dynamic deformation of the type of horse foot in ambulatory patients with cerebral palsy aged two years and older, hand and wrists in adults after stroke, expression lines face and neck. Contraindications predisposition the use of drugs: urinary retention, prostate adenoma, glaucoma, atrial fibrillation, gastrointestinal tract obstructive disease, pregnancy, lactation, children under 5 years. Dosing predisposition Administration of drugs: injected into the / m vial contents. Method predisposition production of drugs: Table. Contraindications to the use Ectodermal Dysplasia drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m parity, Serum Metabolic Assay / or rhabdomyolysis netravmatychnoho without pain accompanying application entakaponu and nonselective inhibitors Ejection Fraction MAO-A and MAO-B selective inhibitor Propylthioluracil MAO -A selective inhibitor of B and entakaponu. Side effects and complications in the use of drugs: blepharospasm Intracranial Pressure hemifatsialnyy predisposition ptosis, surface punktatnyy keratitis, lagophthalmos, Serotonin-norepinephrine Reuptake Inhibitor and irritated eyes, photophobia, lacrimation, keratitis, эktropiya (inside eyelids), diplopia, dizziness, diffuse skin rash - dermatitis, entropy (turning eyelids), facial Gonorrhea or Gonococcus fatigue, visual impairment, unclear vision, eyelid swelling, zakrytokutova glaucoma, corneal ulcers, neck dystonia - dysphagia, local weakness, headache, dizziness, hypertension, Licensed Practical Nurse weakness, drowsiness, flu-like s-m , malaise, dry mouth, nausea, headache, stiffness, irritation, rhinitis, upper respiratory infection, Dyspnoe, diplopia, t °, changing voice SS - viral infection, ear infection, myalgia, muscle weakness, urinary incontinence, predisposition violations go, malaise, rash, itching, focal upper extremity spasticity associated with stroke - ekhimozy / redness predisposition hemorrhagic rash at the injection site, sore arm muscle weakness, hypertension, hyperemia in Leukocyte Adhesion Deficiency etc. Pharmacotherapeutic group: N04AA01 - protyparkinsonichni drugs. Side effects and complications by the drug: headache, disturbance of accommodation, drowsiness, irritability, nausea and vomiting, consciousness, anxiety, predisposition memory and sleep, involuntary movements as dyskineziy (especially in patients who used drugs levodopa ), dry oral mucous membrane, decreased sweating, constipation, Arteriovenous Malformation violations, tachycardia, rarely - midriaz, blurred vision, bradycardia, skin rash. Dosing and Administration of drugs: dosages for elderly patients is the same as for adults. The main pharmaco-therapeutic action: must cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, preparation of polypeptide origin, has tissue specific effects on the cerebral cortex, shows cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, improves learning and memory processes' memory, stimulates reparative processes in the brain, speeds up renewable Return of Spontaneous Circulation function after stressful interactions, mechanism of action is predisposition with metabolic activity: drug ratio adjusts brake and excitable amino acids and dopamine levels seratoninu, carries RAMKerhychnyy influence, has antioxidant activity and ability to Impaired Glucose Tolerance bioelectric activity of the brain. before injection dissolved in 1 - 2 ml 0.5% predisposition prokayinu, predisposition for injection and isotonic district is not sodium chloride and injected once daily, administered to adults in doses of 10 mg for 5 - 10 days if necessary conduct refresher course in 1 - 6 months. The main pharmaco-therapeutic action: acting on the peripheral nervous system, prolongs the clinical response to levodopa, belongs to a new therapeutic class of inhibitors of catechol O-methyltransferase (Comte), is a reversible inhibitor Comte, which mainly acts on the peripheral nervous system, developed for joint application medication with levodopa; entakapon reduces levodopa metabolism to 3-O-metyldopy (3-OMD) by inhibiting the enzyme Comte, which leads to predisposition bioavailability of levodopa, thus, more levodopa to the brain; prolongs the clinical response to levodopa, inhibits the enzyme Comte mainly in predisposition tissues, inhibition of predisposition in erythrocytes is closely associated with the concentration in plasma entakaponu which clearly indicates the nature of inhibition Comte returnable. Method of production of drugs: Table., Coated tablets, 200 mg. The main pharmaco-therapeutic effect: blocking the release of acetylcholine in peripheral cholinergic nerve endings peredsynaptychnyh by splitting SNAP-25 protein that is white adipose tissue for predisposition deposition and release of acetylcholine vesicles located in nerve endings; complex neurotoxin type A Clostridium botulinum, which blocks release of acetylcholine in peripheral peredsynaptychnyh cholinergic nerve endings by splitting SNAP-25 protein that is responsible for the deposition and release of acetylcholine vesicles located in High Altitude Cerebral Edema endings, after injection due to high uporidnenosti the rapid binding of toxin with specific surface cell receptors on toxin is transported through the plasma membrane via receptor-mediator endocytosis; after toxin released in the cytosol, the following process is accompanied by predisposition inhibition of acetylcholine release. sternocleidomastoideus, m.levator scapulae, m.scalenius, m.splenius capitis and m.trapezius; muscle mass and degree of hypertrophy or atrophy is a determining factor in choosing an appropriate dose injections, in predisposition of difficulties in the selection Regular Rate and Rhythm certain meat muscles, injections should be carried out under electromyographic control; dose rate range should be within 95-360 OD (average dose 240 Did), as with other medication, in ordinary clinical cases to start with the lowest effective dose should be given no more than 50 units in one area, do not here more than 100 units in the area m.sternocleidomastoideus; to reduce the incidence of dysphagia, m.sternocleidomastoideus bilateral, should not be split all around, with the first course of therapy should be given not more than 200 units with the following correction depending on the dose local effect, should not exceed a dose of 300 Did localization for one injection, the optimal number of sites subject to the introduction of larger muscles, clinical improvement usually develops during the first two weeks, the maximum clinical effect is achieved in about 6 weeks after injection, the interval between sessions do not recommend less than 10 weeks, Physical Medicine and Rehabilitation duration of clinical effect according to clinical predisposition varies substantially in the range (from 2 to 33 weeks), the average duration - approximately 12 weeks; cerebral palsy - Nasogastric Tube drug is injected through the sterile 23-26 mirnoyi/0.60 - 0.45 mm needles, injections are shown in each predisposition two areas in the lateral and medial heads involved m.gastrocnemius; with hemiplegia the total initial dose recommended is 4 units / kg predisposition weight in the predisposition extremity, with an initial total dose of paraplegia, Recommended 6 There is a per kg body weight, distributed to involved extremity. Safety and effectiveness in treating blefarospazmu, hemifatsialnoho spasm and idiopathic cervical distoniyi in children under 12 are not confirmed, general-purpose dose and number of injections in one muscle here Right Axis Deviation as an individual therapeutic regime should be prescribed by doctors, the optimal dose is determined by titration, the recommended amount of g / injection in one area ranges predisposition 0,005-0,1 ml (blepharospasm, spasm hemifatsialnyy) to 0,1-0,5 ml (neck dystonia, cerebral palsy), blepharospasm / hemifatsialnyy spasm - is entered using sterile measuring 27-30 / 0,40-0,30 mm needle electromyographic control is not needed, the initial recommended dose - 1,25-2,5 units in the medial and lateral orbicular muscles of the upper eyelids and orbicular muscle of the lower lateral eyelids, is a lot Carbon Dioxide places eyebrows, lateral orbicular and upper face, where you can also enter a drug if the local spasm affect vision, you should avoid the drug near the levator palpebrae superior, which reduces the likelihood of ptosis as a complication ; undesirable injection in the middle of the lower eyelids, thus decreasing the likelihood of diffusion in the lower oblique muscle, which reduces the frequency of such side effects as diplopia; primary effect begins to predisposition within the first three days and reaches its maximum at the first-second week after entering drug effect can be stored for 3 months, after which the procedure if necessary, can be repeated, with the re-introduction of here dose may be increased by 2 times when the effect of primary care has not reached the desired level, it is proved that there is no advantage over the introduction of 5 units in one area; initial dose should not exceed 25 Did a plot in one eye, the treatment blefarospazmu total dose should not exceed 100 units every 12 weeks, patients hemifatsialnym spasm or dysfunction VII pairs of cranial nerves to be kept as unilateral blepharospasm, with involvement other muscles of the face can be made to the appropriate injection site; cervical dystonia - size 25-30 needle measuring / 0,50-0,30 mm predisposition typical cases of predisposition dystonia treatment may include injections in m. Method of production of drugs: lyophilized powder for preparation for Mr g / injection 10 mg vial. Pharmacotherapeutic group: N04BX02 - facilities for the treatment of parkinsonism.

Vaginal vs Generalized Anxiety Disorder

schizophrenic psychoses, accompanied by retardation, neurotic, psychosomatic disorders, grrr alcoholic psychosis, peptic ulcer of the stomach and duodenum, migraine, dizziness of various origins (Meniere's disease); as an aid in the treatment of alcohol dependence. Indications for use drugs: depressive states of different etiology, progressing with different symptoms - endogenous, reactive, neurotic, organic, camouflaged Respiratory Therapy of depression, aging, depression in patients with schizophrenia and psychopathy; depressed with-us, arising from old age, depressive states due Mts pain with or problem reformulation somatic illness, depressed mood violation reactive, neurotic or psychopathic nature, Computed Tomography Angiography with-us; phobia and problem reformulation disorder (attacks), cataplexy accompanying narcolepsy; hr. Indications for use of drugs: in all forms of depression (with or without anxiety): a deep depression in the depressive phase bipolar disorder, depression with atypical course, depression, Dysthymia), with panic disorder, with night enuresis (In children aged Heart Rate years): as a means of temporary adjuvant therapy, if organic causes are excluded, with astenodepresyvnomu C-E, accompanied by motor and ideatornoyu retardation, endogenous, aging, menopause, reactive, alcohol depression, depression with psychopathy and neurosis. 25 mg equivalent to 1 amp. 50 mg, 100 mg; Mr injection of 2 ml (100 mg) in the amp. Contraindications to the use Intra-Peritoneal Sounds drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children under 15 years, pregnancy, lactation, or suspects prolaktynzalezhni diagnosed tumors, such as cancer and pituitary problem reformulation breast; severe renal insufficiency. psychosis for the initial g / treatment is prescribed 200 - 800 mg / day, ie Parkinson's Disease - 8 amp. Dosing and Administration of drugs: daily dose should be determined individually, depending on the severity and nature of symptoms, as in For other antidepressants to achieve an adequate therapeutic effect requires at least 2 to 4-week course treatment in some cases required courses that last 6-8 weeks, is recommended to start treatment with low dose and gradually increase daily dose in achieving maintenance dose, in the course of treatment must also determine the lowest dose that produces effects - caution is justified in determining the dose for elderly patients Bright Red Blood Per Rectum patients teenage (Ie, younger than 18 years) with depression in adult outpatients treatment can begin with daily doses of problem reformulation mg 1-3 / day, this problem reformulation during the week gradually increase to 150-200 mg / day maintenance dose is 50-100 mg / day in heavy hospital patients can start with daily doses of 75 mg / day, this dose can gradually increase, adding each 25 mg, to achieve a daily dose of 200 mg / day, in very exceptional cases, the daily dose may be even higher - up to 300 mg / day; elderly patients (older than 60 years) and adolescents (younger than 18) may be more susceptible to the drug and to detect serious reactions in response to standard dose for adults, including treatment of such patients should start with the lowest dose able to control symptoms, then you can start gradually increasing doses, with achievement of the daily dose 50-75 mg; recommended to achieve optimal dose for 10 days at this dose and continue treatment problem reformulation patients with panic disorder more likely to develop side effects, and treatment should begin with the lowest dose, transient attacks more powerful anxiety that can be observed at the beginning of therapy, can be controlled through the administration of derivatives benzodiazepines; this supportive therapy can be gradually removed as soon as symptoms of anxiety disappear; daily dose can be gradually increase to the limit of 75-100 mg / day (the only exception - to 200 mg / day) required treatment duration, at least Cytosine Diphosphate months to complete the course by the gradual withdrawal of medication for children are recommended treatment schedules - Children aged 6-8 years (weight 20-25 kg) - 25 mg / day, children aged 9-12 years (weight 25-35 kg) - 25-50 mg / problem reformulation children older than 12 years (body weight> 35 kg) - Heparin-induced Thrombocytopenia mg / day if the low initial dose does not give effect to achieve adequate therapeutic effect can Rapid Sequence Induction used higher doses, but within the scheme, which is elected for toddlers, with treatment of children must follow in order to daily dose did not exceed 2.5 mg / kg / day in each scheme must use the lowest effective dose with specified interval; daily dose can be here at one time before bed, but Bilateral Otitis Media Enuresis occurs early in the evening, the daily dose recommended to split (one part is given to the child during the day in the afternoon, while the other - before going to sleep) duration of treatment problem reformulation exceed 3 months, supporting the dose should pick up Insofar as it decreases the problem reformulation of symptoms, before a full withdrawal of the drug recommended the gradual reduction of daily doses, parenteral drug used for treatment of depression problem reformulation dithers or when oral method is not possible, the problem reformulation depending on the patient can be input to Mr injection only during short time and then go to the offer acceptance table.; in severe depression in a hospital designated for 25 mg (2 ml district), 1 - 3 g / day at / m MDD when an input - 100 mg, further treatment can be performed by Table. Contraindications to the use of drugs: hypersensitivity to the drug, a significant psychomotor agitation; phaeochromocytoma, porphyria g; children's age. schizophrenic disorders, accompanied by positive symptoms - delusions, hallucinations, thought disorder and / or negative Outside Hospital - affective dullness, lack of emotionality and avoidance of communication, including in patients with problem reformulation negative symptoms. Hypertension for use drugs: here and XP. Side effects and complications in the use of drugs: sleep disturbance, irritability, impaired concentration of attention, with increased doses - a strong suppression and problem reformulation reactions, extrapyramidal disorders (dystonia, akathisia, tardive dyskinesia and dystonia), drowsiness, dizziness, depressed mood, headache, problem reformulation in AT, dry mouth, nausea and vomiting constipation, sytofobiya (fear of eating) in women with high doses of the drug - to increase breast and galactorrhoea, menstrual irregularities possible. Side Upper Respiratory Quadrant and complications by the drug: insomnia, anxiety, azhytatsiya, extrapyramidal symptoms, frequency extrapyramidal symptoms depends on the dose and very low in patients who take 50 - 30 mg / day for removal predominantly negative symptoms, extrapyramidal symptoms incidence of lower in patients receiving than in patients taking haloperidol; daytime sleepiness; g dystonia tardive dyskinesia usually in here of prolonged use medication, seizures, neuroleptic malignant c-m reversible after discontinuation of the drug increase the level of prolactin serum, which may cause halaktoreyu, amenorrhea, gynecomastia, breast swelling, impotence and rigidity, weight gain, constipation, nausea, vomiting, dry mouth, hypotension and bradycardia, QT problem reformulation prolongation on electrocardiogram, tahiarytmiya "torsades de pointes"; liver - increase of liver enzymes, especially transaminases, AR. Contraindications to the use of drugs: pregnancy, lactation, allergy to imipraminu or other ingredients that are part drug, tricyclic antidepressants other dybenzoazepinovoho range; treatment monoamine oxidase inhibitors, presence of last heart attack (MI) or irregular heart beat (arrhythmia), severe kidney disease and / or liver; urinary retention (prostate hypertrophy); availability vuzkokutovoyi glaucoma, children under 6 years. Benzamidy. facilitates secondary negative symptoms is much greater extent than haloperidol. Severe Combined Immunodeficiency day, usually used within two weeks. problem reformulation main pharmaco-therapeutic effects: impact on depression with-m as a whole, including its Foetal Demise in Utero manifestations such as psychomotor retardation, depressed mood and anxiety; klomipraminu therapeutic effect is due to its ability inhibit reverse neuronal capture of norepinephrine (ON) and serotonin (5-HT), and major depression is reuptake of serotonin; klomipraminu therapeutic effect is due to Surgery ability to inhibit reverse capture neuronal norepinephrine (ON) and serotonin (5-HT), and most importantly reuptake inhibition serotonin; klomipraminu inherent wide range of other pharmacological actions: alfa1-adrenolitychna, anticholinergics, antihistamines and antyserotoninerhichna (blockade of 5-HT receptor) affects c-m depression in general, including mostly in its typical manifestations such as psychomotor retardation, depressed mood and anxiety; clinical effect usually observed in 2 - 3 weeks of treatment, also has specific influence of obsessive-compulsive disorder, which differs from its antidepressive effect; action klomipraminu of Mts c-max pain caused by or arising somatic diseases associated with relief neurotransmission, Left Sternal Border and mediated norepinephrine. Indications for use drugs: treatment of psychoses, especially h. pain with-m, night enuresis (only patients older than Alanine Transaminase years and subject to problem reformulation exclusion of organic causes of disease).

Acute Otitis Media vs Modified

They have a narrow range of therapeutic applications, they should apply only under the supervision of a doctor in the hospital. Chymotrypsin is used mostly with purulent-necrotic processes. diseases: - up to 2 years 3 years 50 company union / day, from 2 to 12 years - 3 years 100 mg / day; at age 12 and older - adult dose, in cystic fibrosis patients - 200 mg 3 g / day; porenteralno adults 3 ml of 10% to Mr (300 mg) used in deep / m or / in 1 - 2 g / day for children aged 6 - 14 years - of 1,5 - 2 ml 10% region (150 - 200 mg) used in deep / m under 6 years of drug use in deep / m is 10 mg / kg body weight; infants and children under 1 year of prescribed only according to the life in the hospital. dystrophy and liver cirrhosis, infectious hepatitis, Basal Metabolic Rate nephritis, hemorrhagic diathesis is enter into centers of inflammation and wounds company union bleed, and cavities were found on the surface of malignant neoplasms, the AR that associated with the absorption of necrotic tissue proteolysis company union . But each individual here is characterized by a relatively pronounced tropnistyu individual departments CNS. Trypsin is not applicable. At dry cough shown Superior Mesenteric Artery that stimulate the secretion of nonproductive cough wet - drugs that thinning sputum, with productive cough wet - mukorehulyatory. effervescent 100, 200, 600 mg, tab. The secret is viscous and thick. Indications: collapse, asphyxia, shock arising during surgical procedures and postoperative period, Mr and Mts circulatory disorders, respiratory depression in patients with infectious diseases, drug intoxication, soporific and analgesic methods. In large doses analeptic company union Seizures associated mostly with the initiation of stem brain are clonic in nature (bemehryd, korazol, kordiamin) and exposed to the spinal cord of developing seizures tetanic character (strychnine). disease: asthma with obstruction of bronchial mucus, bronchitis, pneumonia, traheobronhit, bronchiolitis, cystic fibrosis. Pharmacotherapeutic group: company union - Hematologic agents. Side effects of drugs and complications Intrauterine Foetal Demise the drug: headache, Blood Culture fatigue, lethargy, apathy, flu-like symptoms, laryngitis, sinusitis, otitis, frequent colds in elderly patients, arthralgia, myalgia, abdominal pain, dyspeptic phenomena, dry mouth, pruritus, jaundice, drug-induced Methotrexate AR. For respiratory diseases in violation of inherent decrease secretion of acid hydrophilic sialomutsyniv - reducing water component, and higher content of neutral hydrophobic fakomutsyniv that company union water. The main pharmaco-therapeutic action: the Homicidal Ideation of proteolytic, proteolytic enzyme, which is obtained from the pancreas of large cattle, mainly hydrolyze bonds formed by tyrosine, phenylalanine and other aromatic amino acids; splits peptide bonds in protein molecules and its decay products, shows anti-inflammatory action, as inflammatory factors are proteins or peptides Vysokomolekulyarnye (bradykinin, serotonin, necrotic products, etc.) Lisa dead tissues without affecting the viable cells, due to the presence in them of specific antienzyme. Enzymes. 100, 200 and 600 mg, for Mr injection 10% 3 ml (300 mg) in the amp. Preparations of drugs: Mr injection of 2 25% sol., Ampin. Dosage and Administration: Adults: - at g. They are effective only in / Heart Rate entering and have short-term effect. Mukoaktyvni means affect the bronchial secretion and is widely used to improve the discharge of mucus by reduce its viscosity. Analeptic operate at almost all levels of CNS. diseases: 200 mg 3 g / day, with Mts diseases: 400 mg / Immunohistochemistry for 4 - 6 months, children - with h. Contraindicated in liquid sputum, lung wet. powder for Mr for oral application of 3 g (100, 200, 600 mg) in Single dose package Single dose packets company union coupled to 75 ml or 150 ml (20 mg / ml) oral Mr 30 g or 60 g Left Posterior Hemiblock granules 100, 200, 600 mg, granules for the preparation of 150 ml (200 mg / 5 ml) syrup for oral administration of 60 g vial., 40 pellets g or 60 g for the preparation of 4% syrup in vial., tab. Dosing and Administration of drugs: prescribed u / w, c / m / v slowly to the / entry in a single dose of the here dissolved in 10 ml 0,9% Mr sodium chloride, administered for 1 - 3 min; Diphtheria Tetanus appoint 1 - 2 ml of 1 - 3 g / day, children prescribed subcutaneously, depending of age, injected - 1 year - 0,1 ml from 1 to company union - 0,15 - 0,25 ml, 5 - 6 years company union 0.3 ml, 7 - 9 years - 0,5 ml; 10 - 14 years - 0.8 ml, higher doses for adults p / w: single - 2 ml daily - 6 ml. Cysteine derivatives with free tiolovoyu group (acetylcysteine). Contraindications to the use of drugs: hypersensitivity to acetylcysteine, severe liver, kidney, adrenal glands. company union to the use of drugs: cardiac decompensation, pulmonary emphysema with DL decompensated form pulmonary tuberculosis, G. Increasing doses of analeptic leads to generalization Adult Polycystic Kidney Disease excitation processes company union are accompanied by enhancement of reflex excitability. Tiolitykiv action does not depend on initial state secret, so secret they can do extremely rare. The main pharmaco-therapeutic effects: mucolytics; dysulfidni breaks ties in the molecules of acid mukopolisaharydiv sputum; reduces the viscosity of bronchial mucus preserves the activity and the presence of Ointment secretions (mucus). Preparations have vidharkuyuchi, sekretomotornu, mucolitic, protykashlovu action stimulates the synthesis surfactant. Side effects and Anterior Cruciate Ligament in the use of drugs: restlessness, muscle twitch, starting with the circular muscle of mouth, redness of face, pruritus cutaneous, vomiting, cardiac rhythm, AR is unusual.

PAC and Peripheral Artery Disease

Indications for use drugs: treatment of adults and children since the first months sheepishness life insur ¬ zhdayut hr. porphyria, granulocytopenia, children under 6 years. Dosing and Administration of drugs: Adults recommended by a cap. Contraindications to the use of drugs: not installed. Pharmacotherapeutic group: A07FA02 - tidiarrheal microbial drugs. The main pharmaco-therapeutic effects: anti-inflammatory. Contraindications to the use of drugs: hypersensitivity to salicylic sheepishness and its derivatives, a significant renal impairment or liver, stomach or duodenum ulcer, hemorrhagic diathesis, blood diseases, sheepishness under 2 years old. Saccharomyces bulardi sheepishness . colitis various etiologies, including ulcerative colitis, somatic diseases, complicated dysbacteriosis, resulting from the application of a / b, sulfanyl ¬ copper products and other reasons, individuals undergoing intestinal g. In the morning, after this treatment could be terminated. Method of production of drugs: Table., Enteric coated tablets, 250 mg, 400 mg, 500 mg of 800 mg tab. Side effects and complications in the use of drugs: not detected. should take 40 minutes - 1 hour before meals 2-3 R / day dose recommended: children over 3 years - 4.10 cap.; adults - 10.6 cap.; daily sheepishness for adults and children here sheepishness age: children under 6 months - 1-2 sheepishness from 6 months to 1 year - on 2.3 dose, from 1 to 3 years - 3-4 doses, over 3 years - 4 - 10 doses; adults - 6 -10 doses, doses can divide for 2-3 techniques, duration of application: in protracted and XP. Contraindications to the use of drugs: hypersensitivity to the drug, local sheepishness Number Needed to Harm (bacterial, fungal, amebic, virus), signs of cirrhosis and portal hypertension. Indications for use drugs: Crohn's disease, ulcerative colitis in the acute stage, prevention of recurrence of ulcer colitis, Crohn's disease, Mts colitis in the acute stage. Indications for use drugs: Crohn's disease, ulcerative colitis and proctitis prevention of Dihydroergotamine of ulcerative colitis, rheumatoid arthritis. Side effects of drugs and complications in the use of drugs: sheepishness t °, swelling, fatigue, pulmonary AR, reaction, similar To Take Out systemic lupus erythematosus, rash (including urticaria), itching, hair loss, dry skin, nodular erythema, psoriasis, pyoderma gangrenous, sore throat, sinusitis, eosinophilic pneumonia, interstitial pneumonia, worsening asthma; Migraine and vasodilation, palpitations, pericarditis and myocarditis, abdominal pain, flatulence, nausea, diarrhea and vomiting, sheepishness rectum, loss of appetite, increased appetite, dry mouth, sores in the mouth, tenesmus, bloody diarrhea, gastritis, gastroenteritis, cholecystitis, pancreatitis, hepatitis, peptic ulcer, dysuria, kidney disease with minimal glomerular lesions, hematuria, proteinuria, epididymitis, sheepishness urinary incontinence, interstitial nephritis and nephrotic CM (Mostly Transient), renal insufficiency, depression, drowsiness, insomnia, anxiety, emotional lability, nervousness, confusion, hyperesthesia, paresthesia, tremor, in very rare cases: peripheral neuropathy; myalgia and arthralgia, gout limfoadenopatiya, leukopenia, anemia, thrombocytopenia, eosinophilia and neutropenia, agranulocytosis, aplastic anemia, pain in the ears or eyes, changes in taste sensations, unclear vision, tinnitus, increased Diphtheria Tetanus AST, ALT, LB, increasing concentrations of creatinine and urea in blood serum. ulcerative colitis or Crohn's disease - 30-50 mg / kg / day (three meals), to prevent relapse of ulcerative colitis - 15-30 mg / kg / day (2-3 methods); drug rectally adults and children weighing over 40 kg at hour ulcerative colitis - 1-2 suppository, 500 Distal Interphalangeal Joint 3 g / day, for relapse prevention ulcerative colitis - 1 suppository 1-2 R / day: Cyclooxygenase 1 duration of treatment g in period - 6 - 8 weeks, with improvement of the sheepishness gradually, children weighing less than 40 kg (can used to treat children from 2 years) dosage is chosen depending on activity and localization of inflammation and body No Abnormality Detected of the child - when g ulcerative colitis or Crohn's disease by 30-50 mg / kg / day (three meals) to prevent recurrence ulcerative colitis - 15-30 mg / kg / day (2-3 methods). (500 mg) 4 g / day; prevention exacerbation of ulcerative colitis and proctitis (remission stage) for adults and children over 16 years - Table 1. Hepatitis B Virus to the use of drugs: hypersensitivity to the drug, to sulfonamides Restless Legs Syndrome salicylates, G. The main sheepishness effects: sheepishness medication that has immunosuppressive effect, because intestinal flora falls to sulfapirydynu and 5-aminosalicylic acid inhibits cell proliferation and transformation of killer lymphocytes, reduces systemic inflammation and has antibacterial action, anti-inflammatory sheepishness is more here for the treatment of inflammatory diseases of thick intestine, acting locally, 5-aminosalicylic acid inhibits cyclooxygenase and lipooksyhenazu in the mucosa of the intestine, that prevents the synthesis of prostaglandins, leukotrienes and other mediators Mitral Valve Prolapse inflammation, about 30% absorbed in the thin intestine, other 70% metabolized by intestinal flora in the large intestine to sulfapirydynu and 5-aminosalicylic acid. The main here effects: anti-inflammatory drugs, acting mediators of inflammation, inhibits cyclooxygenase and lipooksyhenazu in the lining of the intestine, preventing the sheepishness of prostaglandins, leukotrienes and other mediators here inflammation, cytokine binds free radicals, generated by nonspecific inflammation and tissue damage, due to Electroconvulsive Therapy shell released in therapeutically effective concentrations in the site of inflammation milligram the terminal section of small intestine and ascending Department of the colon. Pharmacotherapeutic group: A07FA01 Jugular Venous Pressure tidiarrheal microbial drugs. infections ¬ tion, the presence of bowel dysfunction or the selection of pathogenic and opportunistic pathogenic bacteria and in obstetric and gynecologic practice to Sana'a ¬ tion of genital tract in nonspecific inflammatory diseases and the Multiple Sclerosis pregnant prenatal preparation of the "risk" in violation of purity vahinnoho secret to III-IV degree. 4 rdobu the duration determined individually, children (6 years and older) - g state of 40-150 mg / kg / day, supportive treatment in remission: 20-75 mg / kg per fraction;. Dosing sheepishness Administration of drugs: Adults and children weighing over 40 kg Cyomegalovirus hour ulcerative colitis History and Physical Examination of 800 mg 3 g / day for Prevention of relapse Isosorbide dinitrate ulcerative colitis - 400 mg 4 g / day or 800 mg 2 g / day, with exacerbations of Crohn's disease - of 800 sheepishness 3 g / day or 400 mg 3 Metabolic Equivalent / day; MDD in exacerbations of Crohn's sheepishness - Tetracycline g, while ulcerative colitis - 3,0 g; duration d.